EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery

Bo Martin Bibby, Ermina Bach, Mia Christensen, Sanne Fisker, Klavs Würgler Hansen

Diabetic Medicine · 2026-07 · 43 (7)

DOI: 10.1111/dme.70272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 19.03.2026. Verfasst von Bo Martin Bibby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section for Biostatistics, Department of Public Health, Aarhus University, Aarhus C, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Blood Glucose, Insulin Infusion Systems. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Understanding intraindividual variability in glycaemic metrics among users of automated insulin delivery (AID) is essential for interpreting data from continuous glucose monitoring (CGM).

Methods

CGM data over 56 days were collected from 142 individuals with type 1 diabetes using AID systems. Glycaemic metrics were derived from four 14‐day periods and two 28‐day periods.

Results

The 95% limit of agreement for the difference between two measurements of time in range (TIR) from the same individual over 14‐day periods was ±13.4%. The risk that two 14‐day TIR values from the same individual differed by more than 5% points was 46.5%. If TIR was based on two 28‐day periods, the 95% limit of agreement decreased to ±9.0%. The risk that two 28‐day TIR values from the same individual differed by more than 5% points was 27.6%.

Conclusion

A 28‐day CGM sampling period is recommended to minimise random variation and obtain more reliable glycaemic metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinBlood GlucoseInsulin Infusion SystemsHypoglycemic AgentsHumansContinuous Glucose MonitoringFemaleMaleAdultTime FactorsBlood Glucose Self-MonitoringYoung AdultMiddle AgedIntelligent Systems

Stichwörter der Autor:innen

automated insulin deliverycontinuous glucose monitoringtime in rangetype 1 diabetesvariability

Substanzen

InsulinBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Section for Biostatistics, Department of Public Health, Aarhus University, Aarhus C, Denmark.
  • Medical Diagnostic Center, Viborg Regional Hospital, Viborg, Denmark.
  • Steno Diabetes Center, Aarhus, Aarhus University Hospital, Aarhus N, Denmark.
  • Medical Diagnostic Center, Silkeborg Regional Hospital, Silkeborg, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.

Zitieren

APA

Bibby, B. M., Bach, E., Christensen, M., Fisker, S., & Hansen, K. W. (2026). Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery. Diabetic Medicine, 43(7). https://doi.org/10.1111/dme.70272

Vancouver

Bibby BM, Bach E, Christensen M, Fisker S, Hansen KW. Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery. Diabetic Medicine. 2026;43(7). doi:10.1111/dme.70272

BibTeX
@article{Bibby2026,
  author = {Bibby, Bo Martin and Bach, Ermina and Christensen, Mia and Fisker, Sanne and Hansen, Klavs Würgler},
  title = {Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery},
  journal = {Diabetic Medicine},
  year = {2026},
  volume = {43},
  number = {7},
  doi = {10.1111/dme.70272}
}
Kostenlos starten →